To assess the associations of semaglutide with recurrent AUD diagnosis (recurrent medical encounters for AUD diagnosis), the study population included 4254 patients who had active medical encounters for the diagnosis of obesity in 6/202112/2022, were for the first time (new-user design) prescribed semaglutide or non-GLP-1RA anti-obesity medications during 6/202112/2022 (index event), had a diagnosis of AUD on or before the index event and had a diagnosis of at least one of obesity-associated comorbidities on or before the index event
Any observed reductions in inflammation likely reflect improved metabolic control rather than specific anti-rheumatic effects
Tirzepatide quick facts Type: Once-weekly injection How it works: Helps control hunger, fullness, digestion, and blood sugar Main benefit: May help support weight loss and appetite control Used for: Weight management, type 2 diabetes, and moderate-to-severe sleep apnea in adults with obesity Monitoring: Should be prescribed and followed by a licensed healthcare provider Benefits of tirzepatide treatment Tirzepatide may help support weight loss by helping you feel less hungry and fuller longer
The practical points are working closely with your cardiologist, monitoring blood pressure and heart rate as your weight changes, and adjusting anticoagulant or rate-control doses if needed
That refund is automatic, per the brand's published policy